施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

盘后交易 11-21 18:59:38 EST

58.23

+0.35

+0.60%

盘后58.50

+0.27+0.46%

18:39 EST

最高58.48	最低57.47	成交量744.14万
今开58.16	昨收57.88	日振幅1.75%
总市值1,181亿	流通市值1,179亿	总股本20.28亿
成交额4.33亿	换手率0.37%	流通股本20.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":58.23,"timestamp":1732222800000,"preClose":57.88,"halted":0,"volume":7441358,"hourTrading":{"tag":"盘后","latestPrice":58.5,"preClose":58.23,"latestTime":"18:39 EST","volume":256422,"amount":14931447.162294,"timestamp":1732232342262},"delay":0,"floatShares":2024495330,"shares":2028176674,"eps":-3.581986,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.35,"latestTime":"11-21 18:59:38 EST","open":58.16,"high":58.48,"low":57.47,"amount":432586455.44734,"amplitude":0.01745,"askPrice":58.8,"askSize":5,"bidPrice":57.63,"bidSize":312,"shortable":3,"etf":0,"ttmEps":-3.581986,"exchange":"NYSE","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732237200000},"adr":0,"listingDate":-18475200000,"adjPreClose":57.88,"adrRate":0,"dividendRate":0.041216,"preHourTrading":{"tag":"盘前","latestPrice":58.22,"preClose":57.88,"latestTime":"09:29 EST","volume":5013,"amount":290735.431848,"timestamp":1732199392091},"postHourTrading":{"tag":"盘后","latestPrice":58.5,"preClose":58.23,"latestTime":"18:39 EST","volume":256422,"amount":14931447.162294,"timestamp":1732232342262},"volumeRatio":0.548544,"optionData":{"bulkOrders":[{"symbol":"BMY","call":true,"expireDate":1737090000000,"strike":"62.5","timestamp":1732207630610,"price":0.7099999785423279,"volume":1800,"amount":127800,"type":"-"}]},"impliedVol":0.2522,"impliedVolPercentile":0.1349},"requestUrl":"/m/hq/s/BMY/wiki","defaultTab":"wiki","newsList":[{"id":"2484310921","title":"百时美施贵宝上涨1.21%，报57.485美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484310921","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484310921?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:30","pubTimestamp":1732030229,"startTime":"0","endTime":"0","summary":"11月19日，百时美施贵宝(BMY)盘中上涨1.21%，截至23:30，报57.485美元/股，成交9858.39万美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/19233045470511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0321505868.SGD","LU1032466523.USD","BK4559","IE00BFTCPJ56.SGD","LU0321505439.SGD","LU1718418525.SGD","LU2125154935.USD","LU1989771016.USD","BK4007","BK4581","IE00B2B36J28.USD","LU1571399168.USD","LU2242652126.USD","LU0225284248.USD","LU1093756325.SGD","LU0868494617.USD","LU1430594728.SGD","LU1670711040.USD","LU2242646821.SGD","BK4534","IE0002141913.USD","IE00BSNM7G36.USD","LU0882574055.USD","IE0009355771.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","LU2125154778.USD","BK4588","BMY","BK4532","LU1261432733.SGD","BK4585","LU0306807586.USD","LU0456855351.SGD","LU1670710588.SGD","LU2133065610.SGD","LU0061475181.USD","LU0306806265.USD","LU0985481810.HKD","LU2360032135.SGD","LU1670710661.SGD","LU1074936037.SGD","LU1670711123.USD","LU0237698245.USD","LU0225771236.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASB","BAC","AHCO","SCHW","AFG","AMAT","ARE","ASND","LNG","AIN","AESI","AKYA","ALGT","APH","BK4588","CABA","BIIB","LU1267930227.SGD","IE00BKVL7J92.USD","ASTS","CELC","BMY","IE00BBT3K403.USD","BK4534","AAP","ADSK","BL","ALK","BTM","LU1074936037.SGD","AGCO","AHR","AAL","BKR","LU1861217088.USD","BE","AROC","LU1032466523.USD","BRX","BV","ARI","BLUE","BJ","LU0354030511.USD","CHX","AMH","LU0868494708.USD","CAVA","AGYS","BRZE"],"gpt_icon":1},{"id":"2483301914","title":"美股异动丨遭遇67亿美元诉讼，施贵宝跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483301914","media":"港股那点事","labels":["Policy And Regulatory","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483301914?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:19","pubTimestamp":1731687540,"startTime":"0","endTime":"0","summary":"格隆汇11月16日｜施贵宝(BMY.US)跌超3%，报56.42美元。消息面上，公司在周四遭遇一宗价值高达67亿美元的诉讼，指控其通过推迟三种药物的联邦批准来欺骗前Celgene的股东们。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-11-16/doc-incwemza3046645.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-16/doc-incwemza3046645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Policy And Regulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","LU1261432733.SGD","LU0456855351.SGD","LU2360032135.SGD","LU1670710661.SGD","LU0321505868.SGD","LU1571399168.USD","LU0306806265.USD","BK4559","LU2242646821.SGD","BMY","IE00BSNM7G36.USD","BK4532","LU2125154778.USD","LU1718418525.SGD","BK4534","BK4588","LU1074936037.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1032466523.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1093756168.USD","LU0985481810.HKD","LU0061475181.USD","LU1585245621.USD","LU1670711040.USD","LU0306807586.USD","LU1989771016.USD","LU0868494617.USD","LU0225771236.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU0237698245.USD","LU1291159041.SGD","LU0114720955.EUR","LU2125154935.USD","BK4585","LU2133065610.SGD","LU1430594728.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1093756325.SGD","LU2242652126.USD","LU0882574055.USD","BK4007","LU1670710588.SGD"],"gpt_icon":0},{"id":"2483303230","title":"百时美施贵宝下跌3.09%，报56.695美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483303230","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483303230?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:29","pubTimestamp":1731684580,"startTime":"0","endTime":"0","summary":"11月15日，百时美施贵宝(BMY)盘中下跌3.09%，截至23:29，报56.695美元/股，成交2.69亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：11月12日，百时美施贵宝获蒙特利尔资本市场上调目标价至61美元，最新评级Market Perform。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/15232945362087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0456855351.SGD","LU1430594728.SGD","LU1718418525.SGD","IE00BFTCPJ56.SGD","BK4585","LU2242646821.SGD","BMY","LU1670711040.USD","LU1989771016.USD","LU0306807586.USD","LU0868494617.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU2125154778.USD","BK4007","BK4581","LU1032466523.USD","LU1093756325.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU1585245621.USD","LU0321505868.SGD","LU0985481810.HKD","LU2133065610.SGD","LU1074936037.SGD","IE00B2B36J28.USD","LU2125154935.USD","IE0002141913.USD","BK4532","LU2242652126.USD","LU1670710588.SGD","LU1670710661.SGD","LU0225771236.USD","LU0061475181.USD","LU1291159041.SGD","LU0225284248.USD","LU1261432733.SGD","LU1670711123.USD","LU0306806265.USD","IE0009355771.USD","BK4534","LU0321505439.SGD","BK4588","LU2360032135.SGD","LU0114720955.EUR","LU0237698245.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","BK4559"],"gpt_icon":0},{"id":"2483846308","title":"BUZZ-特朗普任命小肯尼迪领导美国最高卫生机构后，制药商延续跌势","url":"https://stock-news.laohu8.com/highlight/detail?id=2483846308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483846308?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:13","pubTimestamp":1731683639,"startTime":"0","endTime":"0","summary":" (更新)    11月15日 - ** 在当选总统特朗普选择  Robert F. Kennedy Jr领导美国最高卫生机构卫生与公众服务部之后，疫苗生产商的股价延续跌势。** 在美国上市的生物技术公司   股价下跌~5%，报98.41美元；莫德纳  下跌5.20%，报37.50美元；Novavax  下跌~3%，报7美元；辉瑞  下跌4.05%，报24.97美元。** 欧洲医疗保健公司股票也下跌  ** 美国制药商礼来  股价下跌2.7%，默克  下跌3.34%，安进  下跌3.6%，百时美施贵宝  下跌1.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035775433.USD","LU2237443465.HKD","LU1291159041.SGD","PFE","LU0170899867.USD","IE00B2B36J28.USD","SG9999014542.SGD","LU0320765992.SGD","LU0456855351.SGD","MRNA","LU0417517546.SGD","LU1989772840.SGD","LU1093756168.USD","IE00BN8TJ469.HKD","BMY","LU0882574139.USD","NVAX","LU0094547139.USD","LU1917777945.USD","LU0320765059.SGD","LU1064131342.USD","LU1868836914.USD","LU1894683264.USD","LU0061475181.USD","LU1868836591.USD","LU1718418525.SGD","LU1983299246.USD","SGXZ31699556.SGD","SG9999018857.SGD","MRK","SGXZ57979304.SGD","LU1989771016.USD","LU1280957306.USD","LU0070302665.USD","SGXZ99366536.SGD","LLY","LU0640476718.USD","SG9999015978.USD","LU0096364046.USD","LU0114720955.EUR","AMGN","SG9999002232.USD","BK4007","IE00BBT3K403.USD","LU0306807586.USD","LU0823416689.USD","LU2237443622.USD","SG9999014880.SGD","BK4588","LU1623119135.USD"],"gpt_icon":1},{"id":"2483341379","title":"金十数据整理：每日美股市场要闻速递（11月15日 周五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2483341379","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483341379?lang=zh_cn&edition=full","pubTime":"2024-11-15 21:55","pubTimestamp":1731678909,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MSFT","QQQ","LLY","SDS","159945","ESmain","QID","SMCI","UPRO","RDS.B","LU1989771016.USD","ARTL","159632","03086","SHEL","SQQQ","UN","SPXU","OEF",".SPX","RDS.A","LU0306806265.USD","UL","GM","EQNR","MNQmain","SSO","LU1035775433.USD","SPY","NDX","LU1868837136.USD",".IXIC","ULVR.UK","HTZ","LU1670711040.USD","FTC","RDSA.UK","IVV","OEX","03165","NQmain","SH","QLD","BMY","TQQQ","BP","PSQ","TTE","FTC.AU","JNJ"],"gpt_icon":1},{"id":"2483312245","title":"百时美施贵宝(BMY.US)被质疑拖延抗癌药审批 面临67亿美元诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2483312245","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483312245?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:32","pubTimestamp":1731655925,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国医药巨头百时美施贵宝公司在周四遭遇一宗价值高达67亿美元的诉讼，指控其通过推迟三种药物的联邦批准来欺骗前Celgene的股东们。据了解，该诉讼指控百时美施贵宝在寻求药物批准方面有意拖延，包括其重磅抗癌药物Breyanzi在内的核心药物审批进程被百时美施贵宝管理层有意拖延，进而导致“或有价值权”持有者们每股额外损失9美元现金。此外，法院还表示，没有证据表明百时美施贵宝存在故意拖延或欺诈行为。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMY","LU1291159041.SGD","IE00B2B36J28.USD","BK4585","LU1718418525.SGD","LU2125154935.USD","LU1261432733.SGD","BK4007","LU0321505868.SGD","LU0225284248.USD","LU1074936037.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU1670711123.USD","LU1032466523.USD","LU2242646821.SGD","LU0225771236.USD","LU2360032135.SGD","LU0868494617.USD","BK4559","LU0456855351.SGD","LU1093756325.SGD","IE00BSNM7G36.USD","LU0061475181.USD","LU0985481810.HKD","LU1430594728.SGD","LU0114720955.EUR","LU0321505439.SGD","LU1093756168.USD","IE0009355771.USD","LU0306806265.USD","LU2242652126.USD","BK4588","LU2133065610.SGD","LU0306807586.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","BK4581","IE0002141913.USD","LU2125154778.USD","LU0237698245.USD","IE00BFTCPJ56.SGD","LU1670710588.SGD","LU1670711040.USD","LU0882574055.USD","LU1670710661.SGD","BK4534","BK4532"],"gpt_icon":0},{"id":"2483357658","title":"百时美施贵宝因抗癌药延期上市再次面临 67 亿美元诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2483357658","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483357658?lang=zh_cn&edition=full","pubTime":"2024-11-15 07:43","pubTimestamp":1731627789,"startTime":"0","endTime":"0","summary":"该公司称，百时美施贵宝这样做是为了避免巨额赔偿。百时美施贵宝公司的赔偿责任估计为 67 亿美元，高于之前法庭文件中提到的 64 亿美元。盘后，百时美施贵宝及其律师均未立即回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU0225284248.USD","LU1074936037.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4588","LU0985481810.HKD","LU1571399168.USD","BMY","BK4532","LU0061475181.USD","IE0002141913.USD","LU1585245621.USD","LU2242646821.SGD","LU0321505439.SGD","IE00B2B36J28.USD","BK4581","LU2125154778.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU1670710588.SGD","LU0306807586.USD","IE00BJT1NW94.SGD","LU1032466523.USD","BK4007","LU0456855351.SGD","IE0009355771.USD","LU1670710661.SGD","LU1261432733.SGD","LU0306806265.USD","LU1093756325.SGD","LU2125154935.USD","LU1670711040.USD","BK4559","LU2133065610.SGD","LU1093756168.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU0321505868.SGD","BK4534","LU0868494617.USD","LU1430594728.SGD","LU1718418525.SGD","LU1989771016.USD","LU1670711123.USD","LU0882574055.USD","BK4585","LU0225771236.USD"],"gpt_icon":0},{"id":"2483734836","title":"百时美施贵宝下跌1.25%，报58.285美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483734836","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483734836?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:19","pubTimestamp":1731514762,"startTime":"0","endTime":"0","summary":"11月14日，百时美施贵宝(BMY)盘中下跌1.25%，截至00:19，报58.285美元/股，成交1.33亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：11月12日，百时美施贵宝获蒙特利尔资本市场上调目标价至61美元，最新评级Market Perform。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/14001945270420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4581","LU1261432733.SGD","LU0456855351.SGD","LU2360032135.SGD","LU1670710661.SGD","LU0321505868.SGD","LU1571399168.USD","LU0306806265.USD","BK4559","LU2242646821.SGD","BMY","IE00BSNM7G36.USD","BK4532","LU2125154778.USD","LU1718418525.SGD","BK4534","BK4588","LU1074936037.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1032466523.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1093756168.USD","LU0985481810.HKD","LU0061475181.USD","LU1585245621.USD","LU1670711040.USD","LU0306807586.USD","LU1989771016.USD","LU0868494617.USD","LU0225771236.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU0237698245.USD","LU1291159041.SGD","LU0114720955.EUR","LU2125154935.USD","BK4585","LU2133065610.SGD","LU1430594728.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1093756325.SGD","LU2242652126.USD","LU0882574055.USD","BK4007","LU1670710588.SGD"],"gpt_icon":0},{"id":"2483082300","title":"美国研究综述-AMN 医疗保健服务公司、Chart Industries 公司、家得宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082300?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:30","pubTimestamp":1731497406,"startTime":"0","endTime":"0","summary":"    路透11月13日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 AMN 医疗保健服务公司、Chart Industries 公司和家得宝公司。* 908 Devices Inc   ：Leerink Partners将目标价从12美元下调至4美元             * 908 Devices Inc   ：Leerink Partners 将其目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTLS","MASS","COLD","BLFS","CSX","DOCS","CRNX","AXSM","FDX","LU2133065610.SGD","BK4534","ACLX","BBIO","LU0128525689.USD","LU2106854487.HKD","BK4505","LU2249611893.SGD","HCSG","BMY","ALIT","DOX","BK4566","APA","CLF","SATS","LU2065731478.USD","COGT","BK4567","ABBV","CAVA","ALB","AESI","CHRW","DAY","COTY","HD","CCCS","AMN","ATLC","BHVN","BCAX","BLTE","CHGG","EWTX","LU0256863902.USD","AISP","CHH","DCOM","IRON","ARCH"],"gpt_icon":0},{"id":"2483039815","title":"百时美施贵宝下跌1.25%，报59.07美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483039815","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483039815?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:57","pubTimestamp":1731430650,"startTime":"0","endTime":"0","summary":"11月13日，百时美施贵宝(BMY)盘中下跌1.25%，截至00:57，报59.07美元/股，成交2.83亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/13005745223198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0456855351.SGD","LU1430594728.SGD","LU1718418525.SGD","IE00BFTCPJ56.SGD","BK4585","LU2242646821.SGD","BMY","LU1670711040.USD","LU1989771016.USD","LU0306807586.USD","LU0868494617.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU2125154778.USD","BK4007","BK4581","LU1032466523.USD","LU1093756325.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU1585245621.USD","LU0321505868.SGD","LU0985481810.HKD","LU2133065610.SGD","LU1074936037.SGD","IE00B2B36J28.USD","LU2125154935.USD","IE0002141913.USD","BK4532","LU2242652126.USD","LU1670710588.SGD","LU1670710661.SGD","LU0225771236.USD","LU0061475181.USD","LU1291159041.SGD","LU0225284248.USD","LU1261432733.SGD","LU1670711123.USD","LU0306806265.USD","IE0009355771.USD","BK4534","LU0321505439.SGD","BK4588","LU2360032135.SGD","LU0114720955.EUR","LU0237698245.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","BK4559"],"gpt_icon":0},{"id":"2482773144","title":"美国研究综述-Cable One、Neurogene、Topbuild","url":"https://stock-news.laohu8.com/highlight/detail?id=2482773144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482773144?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:43","pubTimestamp":1731404607,"startTime":"0","endTime":"0","summary":"    路透11月12日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cable One、Neurogene 和 Topbuild。要闻 * Cable One Inc   ：摩根大通将目标价从480美元下调至470美元 * Hudson Pacific Properties Inc   ：杰富瑞将目标价从 \"买入 \"下调至 \"持有  * Neurogene Inc   ：Leerink Partners将目标价从45美元上调至72美元 * Rapt Therapeutics Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU","EOG","LU1003077747.HKD","DOCS","GPMT","JLL","BK4123","EYPT","ARMK","DAL","ARDT","ARCB","HPP","CMTG","AIZ","CDE","CTVA","LU0256331488.USD","BLD","BMY","LU0648001328.SGD","LU2242652126.USD","AL","BK4101","CABO","BAX","APD","FTRE","ABBV","AEO","ALB","LU0211328371.USD","HMN","IE00BBT3K403.USD","BILL","BLMN","DB","FTNT","DKNG","ATLC","ADSK","CACI","AIG","IMXI","AGL","CCL","LU0070302665.USD","AFG"],"gpt_icon":1},{"id":"2482731161","title":"BUZZ-券商观点：艾伯维精神分裂症药物失败 \"将留下印记","url":"https://stock-news.laohu8.com/highlight/detail?id=2482731161","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482731161?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:53","pubTimestamp":1731340387,"startTime":"0","endTime":"0","summary":"11月11日 -  ** 艾伯维ABBV.N称， ，其通过87亿美元收购Cerevel Therapeutics获得的一种实验性精神分裂症药物未能通过两项中期研究，导致该制药商股价暴跌12.5%。** Piper Sandler 称负面结果 \"将留下印记\"。** 券商预计投资者将重新关注艾伯维通过内部研发努力或外部业务开发引入更多增长动力的能力。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4T3MI16H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU1670710588.SGD","LU0708994859.HKD","IE00BVYPNV92.GBP","LU0122379950.USD","BK4588","LU0234570918.USD","LU0868494617.USD","BK4007","IE0004445239.USD","LU0225284248.USD","LU1074936037.SGD","ABBV","LU0211327993.USD","LU0882574055.USD","LU0306807586.USD","LU0553294199.USD","LU0128525929.USD","LU0912757837.SGD","LU0170899867.USD","LU0965508806.USD","LU1571399168.USD","LU1261432733.SGD","LU0965509283.SGD","LU0256863902.USD","BK4585","LU1585245621.USD","LU0545039389.USD","LU0820561818.USD","LU1989771016.USD","LU2242652126.USD","LU0203347892.USD","LU0661504455.SGD","LU0861579265.USD","LU0949170772.SGD","LU0310799852.SGD","LU0795875086.SGD","LU0158827948.USD","LU1023059063.AUD","LU1093756168.USD","LU0985481810.HKD","IE00B42XCP33.USD","BK4534","BMY","LU0310800379.SGD","IE00BFTCPJ56.SGD","LU0211328371.USD","IE00B4R5TH58.HKD","LU0795875169.SGD","BK4559"],"gpt_icon":0},{"id":"2482735862","title":"精神分裂症药物研究失败 艾伯维公司大跌超12% 施贵宝上涨13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735862","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735862?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:51","pubTimestamp":1731336673,"startTime":"0","endTime":"0","summary":"周一，艾伯维公司(ABBV.US)大幅低开，截至发稿，大跌超12%，报174.21美元。消息面上，艾伯维公司表示，最近收购的治疗精神分裂症的艾玛克拉丁候选药物未能在一对中期研究中达到关键目标，艾玛克拉丁的2期研究未达到其主要终点，在第六周未出现患有这种心理健康障碍患者症状严重程度的改善的统计学显著性。公司表示，仍在分析研究数据，以确定下一步的步骤。值得注意的是，施贵宝(BMY.US)却上涨13%，创下2006年3月以来的最大涨幅。分析人士称，这支股票可能是在对艾伯维以上消息做出回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225540a22cf0c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225540a22cf0c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BDGV0183.EUR","IE00BVYPNV92.GBP","LU0170899867.USD","BK4588","IE0004445239.USD","LU0820561909.HKD","LU0965508806.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU2125154778.USD","BK4566","LU0417517546.SGD","LU2360032135.SGD","BMY","LU0234572021.USD","LU0237698245.USD","LU1571399168.USD","LU0211327993.USD","BK4581","LU0949170772.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0321505868.SGD","LU0456855351.SGD","IE00BVYPNW00.USD","LU0234570918.USD","LU2125154935.USD","LU0553294199.USD","LU2242646821.SGD","LU0310800379.SGD","LU0795875086.SGD","LU0912757837.SGD","LU0985481810.HKD","LU1291159041.SGD","LU0820561818.USD","LU0128525929.USD","LU0861579265.USD","LU1093756325.SGD","LU0225284248.USD","LU1670710588.SGD","LU0738911758.USD","BK4533","LU0795875169.SGD","ABBV","LU0965509101.SGD","IE00B2B36J28.USD","LU1093756168.USD","LU0029864427.USD","LU0545039389.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"1144919254","title":"精神分裂症药物研究失败，艾伯维公司大跌，竞争对手施贵宝大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1144919254","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144919254?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:43","pubTimestamp":1731336187,"startTime":"0","endTime":"0","summary":"创下2006年3月以来的最大涨幅。","market":"us","thumbnail":"https://static.tigerbbs.com/81195b8f1f56d11a7f44f9f951806b19","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/81195b8f1f56d11a7f44f9f951806b19"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精神分裂症药物研究失败，艾伯维公司大跌，竞争对手施贵宝大涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","BMY"],"gpt_icon":0},{"id":"2482733326","title":"美股异动 | 精神分裂症药物研究失败 艾伯维公司(ABBV.US)大跌超12% 施贵宝(BMY.US)上涨13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482733326","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482733326?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:40","pubTimestamp":1731336004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，艾伯维公司(ABBV.US)大幅低开，截至发稿，大跌超12%，报174.21美元。消息面上，艾伯维公司表示，最近收购的治疗精神分裂症的艾玛克拉丁候选药物未能在一对中期研究中达到关键目标，艾玛克拉丁的2期研究未达到其主要终点，在第六周未出现患有这种心理健康障碍患者症状严重程度的改善的统计学显著性。公司表示，仍在分析研究数据，以确定下一步的步骤。值得注意的是，施贵宝(BMY.US)却上涨13%，创下2006年3月以来的最大涨幅。分析人士称，这支股票可能是在对艾伯维以上消息做出回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU2125154778.USD","LU0225284248.USD","LU1585245621.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU0306807586.USD","IE00B4R5TH58.HKD","BK4139","LU2133065610.SGD","LU0545039389.USD","LU1718418525.SGD","LU0861579265.USD","LU0310800379.SGD","LU1093756325.SGD","BK4566","BMY","LU0256863811.USD","IE00BJJMRZ35.SGD","LU0225771236.USD","LU1003077747.HKD","LU0321505439.SGD","LU0234570918.USD","LU2242646821.SGD","LU0965509283.SGD","IE00B2B36J28.USD","LU0114720955.EUR","LU2360032135.SGD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU0310799852.SGD","BK4532","LU1670711040.USD","BK4534","LU0882574055.USD","LU0708994859.HKD","LU1571399168.USD","LU1670711123.USD","IE0009355771.USD","ABBV","BK4585","IE00B3PB1722.GBP","LU0795875169.SGD","LU1989771016.USD","LU0122379950.USD","IE0002141913.USD","BK4007","LU0211327993.USD","LU0306806265.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2482738348","title":"施贵宝盘中异动 股价大涨11.87%报60.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738348?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:33","pubTimestamp":1731335598,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时33分，施贵宝股票出现异动，股价快速拉升11.87%。截至发稿，该股报60.57美元/股，成交量301.301万股，换手率0.15%，振幅1.43%。施贵宝股票所在的制药行业中，整体跌幅为0.39%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122331895be10b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122331895be10b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1074936037.SGD","LU0868494617.USD","BK4588","LU1670711123.USD","BK4532","LU1989771016.USD","IE00BJJMRZ35.SGD","LU2125154778.USD","LU1430594728.SGD","LU1718418525.SGD","LU1032466523.USD","LU0114720955.EUR","LU2360032135.SGD","BMY","LU1571399168.USD","LU0237698245.USD","BK4581","IE00BJT1NW94.SGD","IE0009355771.USD","LU0321505868.SGD","LU0306806265.USD","LU0456855351.SGD","LU2133065610.SGD","LU1585245621.USD","LU2125154935.USD","LU0061475181.USD","LU1670711040.USD","LU2242646821.SGD","LU0225771236.USD","LU1670710661.SGD","BK4007","LU2242652126.USD","LU0985481810.HKD","IE00BSNM7G36.USD","LU0321505439.SGD","LU1291159041.SGD","LU0882574055.USD","LU1093756325.SGD","LU0225284248.USD","LU1670710588.SGD","IE00BFTCPJ56.SGD","BK4534","BK4559","IE0002141913.USD","IE00B2B36J28.USD","BK4585","LU1093756168.USD","LU0306807586.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2482782037","title":"BUZZ-精神分裂症药物中期研究失败，艾伯维业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2482782037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482782037?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:08","pubTimestamp":1731334116,"startTime":"0","endTime":"0","summary":"** 竞争对手百时美施贵宝  的股价盘前上涨13%至61.13美元 ** BMY的药物Cobenfy是一种治疗精神分裂症的新型药物，已于9月份获得美国FDA批准。** 精神分裂症是一种导致持续妄想和幻觉的疾病，严重影响患者对现实的感知能力 ** 截至上次收盘，ABBV 累计上涨约 29%，BMY 累计上涨 5.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BVYPNW00.USD","LU0225284248.USD","LU1585245621.USD","LU2242652126.USD","BK4139","LU2133065610.SGD","LU0545039389.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1718418525.SGD","LU0861579265.USD","LU1093756325.SGD","LU0321505868.SGD","BMY","LU0256863811.USD","LU0949170772.SGD","LU0738911758.USD","LU0985320562.USD","LU0170899867.USD","LU1003077747.HKD","LU0256863902.USD","LU0029864427.USD","LU0321505439.SGD","LU0943347566.SGD","LU1074936037.SGD","LU0234570918.USD","LU0234572021.USD","BK4559","LU0965509283.SGD","IE00B2B36J28.USD","LU0114720955.EUR","LU0912757837.SGD","LU2360032135.SGD","LU0417517546.SGD","LU0965509010.AUD","LU1430594728.SGD","LU0310799852.SGD","LU1670711040.USD","BK4534","LU0708994859.HKD","LU0553294199.USD","ABBV","LU0128525929.USD","BK4585","LU1670710588.SGD","LU0965508806.USD","LU1670710661.SGD","IE00BGHQF631.EUR","BK4007"],"gpt_icon":0},{"id":"2482245805","title":"百时美施贵宝下跌1.23%，报54.035美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482245805","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482245805?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:44","pubTimestamp":1731098690,"startTime":"0","endTime":"0","summary":"11月9日，百时美施贵宝(BMY)盘中下跌1.23%，截至04:44，报54.035美元/股，成交2.93亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/09044445108679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0985481810.HKD","LU1670710661.SGD","LU0456855351.SGD","LU1074936037.SGD","LU2125154935.USD","LU0061475181.USD","LU0321505868.SGD","LU1571399168.USD","LU2133065610.SGD","LU2242646821.SGD","LU2360032135.SGD","LU1093756325.SGD","BK4581","IE00BFTCPJ56.SGD","LU0237698245.USD","LU0114720955.EUR","LU1261432733.SGD","LU1430594728.SGD","BK4007","IE0002141913.USD","LU1032466523.USD","LU0321505439.SGD","LU1670710588.SGD","LU0225284248.USD","LU1291159041.SGD","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","LU0225771236.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","BMY","LU0882574055.USD","LU1585245621.USD","LU1670711123.USD","LU1670711040.USD","IE00B2B36J28.USD","LU1718418525.SGD","BK4534","IE00BJT1NW94.SGD","BK4532","IE00BSNM7G36.USD","LU1093756168.USD","BK4588","LU2125154778.USD","LU0306806265.USD","LU0306807586.USD","BK4585","BK4559"],"gpt_icon":0},{"id":"2482485946","title":"施贵宝2024财年第三财季实现净利润12.11亿美元，同比减少37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485946?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081628,"startTime":"0","endTime":"0","summary":"11月9日，施贵宝公布财报，公告显示公司2024财年第三财季净利润为12.11亿美元，同比减少37.19%；其中营业收入为118.92亿美元，同比增加8.44%，每股基本收益为0.60美元。机构评级：截至2024年11月9日，当前有20家机构对施贵宝目标价做出预测，其中目标均价为53.80美元，其中最低目标价为36.00美元，最高目标价为64.00美元。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000144a224f640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000144a224f640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":-0.0091},{"period":"1month","weight":0.1105},{"period":"3month","weight":0.2155},{"period":"6month","weight":0.4035},{"period":"1year","weight":0.1939},{"period":"ytd","weight":0.128}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司，通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.013265},{"month":2,"riseRate":0.545455,"avgChangeRate":0.009113},{"month":3,"riseRate":0.636364,"avgChangeRate":0.008429},{"month":4,"riseRate":0.488889,"avgChangeRate":-0.002113},{"month":5,"riseRate":0.577778,"avgChangeRate":0.003555},{"month":6,"riseRate":0.622222,"avgChangeRate":0.010543},{"month":7,"riseRate":0.422222,"avgChangeRate":-0.000341},{"month":8,"riseRate":0.511111,"avgChangeRate":-0.003031},{"month":9,"riseRate":0.533333,"avgChangeRate":0.011131},{"month":10,"riseRate":0.577778,"avgChangeRate":0.025202},{"month":11,"riseRate":0.622222,"avgChangeRate":0.02077},{"month":12,"riseRate":0.636364,"avgChangeRate":0.022108}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}